Long-Term Assets: The sum of all assets classified as non-current.
VistaGen Therapeutics, Inc. (VTGN) had Long-Term Assets of $1.62M for the most recently reported fiscal year, ending 2026-03-31.
| Income Statement Financials | |
$1.27M |
|
$-69.69M |
|
-- |
|
$1.27M |
|
$73.39M |
|
$-72.13M |
|
$2.45M |
|
$-69.68M |
|
$-69.68M |
|
$-69.67M |
|
$-69.67M |
|
$-69.69M |
|
$-69.67M |
|
$-72.13M |
|
$-72.47M |
|
38.07M |
|
38.07M |
|
$-1.83 |
|
$-1.83 |
|
| Balance Sheet Financials | |
$46.94M |
|
$0.43M |
|
|
Long-Term Assets |
$1.62M |
$48.56M |
|
$12.79M |
|
-- |
|
$0.25M |
|
$13.04M |
|
$35.52M |
|
$35.52M |
|
$35.52M |
|
39.62M |
|
| Cash Flow Statement Financials | |
$-66.44M |
|
$-0.88M |
|
$30.97M |
|
$67.13M |
|
$30.79M |
|
$-36.34M |
|
$4.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.67 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
100.00% |
|
-5683.69% |
|
-5683.69% |
|
-5710.80% |
|
-5490.78% |
|
-5491.33% |
|
$-66.59M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-196.15% |
|
-196.15% |
|
-143.46% |
|
-196.15% |
|
$0.90 |
|
$-1.75 |
|
$-1.74 |
|